DM0000: The mark consists of the word "Ethypharm" in block letters (the letter "E" is in upper case and the other letters are in lower case), which is plum (Pantone 262 C) in color; under the name "Ethypharm" there is a blue (Pantone Process Blue C) horizontal line to the left and the three words "INNOVATIVE DRUG DELIVERY" in small capital letters to the right, which are plum (Pantone 262 C) in color; to the left of these elements there is an upside-down exclamation mark, which is plum (Pantone 262 C) in color, surrounded by a blue (Pantone Process Blue C) crescent.
GS0051: Pharmaceutical preparations for the treatment of cancer, central nervous system disorder, hormonal disorder, metabolic disorder, immunologic disorder, cardiovascular system disorder, infection, pain, addiction, ophthalmological disorder, gynecological disorder, dermatological disorder; veterinary preparations for the treatment of animal disease, in the nature of cancer, central nervous system disorder, hormonal disorder, metabolic disorder, immunologic disorder, cardiovascular system disorder, infection, pain, addiction, ophthalmological disorder, gynecological disorder, dermatological disorder; sanitary preparations for medical purposes, namely, alkaline solution, chloride, tensioactive substance, iodine; Dietary food supplements, namely, protein supplements, infant formulas, preparation of herbal origin to be used for slimness, cleansing digestion, circulation and relaxation, vitamins, minerals, lecithin, meal replacement in the form of bars, drinks and capsules; Disinfectants pertaining to the pharmaceutical sector, namely, alkaline solution, chloride, tensioactive substance, iodine for hygienic purposes
CC0000: The color(s) plum (Pantone 262 C) and blue (Pantone Process Blue C) is/are claimed as a feature of the mark.
D10000: "INNOVATIVE DRUG DELIVERY"
GS0421: Research and development of new technologies in the medical and pharmaceutical fields; research and development in the field of galenic innovation; research and development in the field of medical solutions; medical and clinical studies, namely, scientific research services for medical purposes; research and development for others in the medical and pharmaceutical fields; engineering in the medical and pharmaceutical fields; chemical research; chemical analysis
Case File Event Statements
11/5/2023 - 7 months ago
41 - TOTAL INVALIDATION PROCESSED BY THE IBType:INNT
10/16/2023 - 8 months ago
40 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IBType:INTS
10/16/2023 - 8 months ago
39 - INVALIDATION PROCESSEDType:INPC
10/10/2023 - 8 months ago
38 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATEDType:INTR
2/10/2023 - a year ago
37 - CANCELLED SECTION 71Type:C71T
6/3/2021 - 3 years ago
36 - INTERNATIONAL REGISTRATION RENEWEDType:RNWL
5/15/2021 - 3 years ago
35 - CHANGE OF NAME/ADDRESS REC'D FROM IBType:ADCH
12/12/2019 - 4 years ago
34 - NEW REPRESENTATIVE AT IB RECEIVEDType:NREP
11/8/2019 - 4 years ago
33 - NEW REPRESENTATIVE AT IB RECEIVEDType:NREP
12/13/2018 - 5 years ago
32 - NEW REPRESENTATIVE AT IB RECEIVEDType:NREP
8/14/2018 - 5 years ago
31 - NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - MAILEDType:NA75
8/14/2018 - 5 years ago
30 - REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.Type:C75A
8/10/2018 - 5 years ago
29 - CASE ASSIGNED TO POST REGISTRATION PARALEGALType:APRE
7/24/2018 - 5 years ago
28 - TEAS SECTION 71 & 15 RECEIVEDType:ES75
3/19/2013 - 11 years ago
27 - FINAL DECISION TRANSACTION PROCESSED BY IBType:FINO
10/26/2012 - 11 years ago
26 - FINAL DISPOSITION NOTICE SENT TO IBType:FICS
10/26/2012 - 11 years ago
25 - FINAL DISPOSITION PROCESSEDType:FIMP
10/24/2012 - 11 years ago
24 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IBType:FICR
7/24/2012 - 11 years ago
23 - REGISTERED-PRINCIPAL REGISTERType:R.PR
5/8/2012 - 12 years ago
22 - PUBLISHED FOR OPPOSITIONType:PUBO
4/18/2012 - 12 years ago
21 - NOTICE OF PUBLICATIONType:NPUB
4/4/2012 - 12 years ago
20 - LAW OFFICE PUBLICATION REVIEW COMPLETEDType:PREV
4/4/2012 - 12 years ago
19 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
3/14/2012 - 12 years ago
18 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
3/13/2012 - 12 years ago
17 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
3/13/2012 - 12 years ago
16 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
1/17/2012 - 12 years ago
15 - NON-FINAL ACTION MAILEDType:CNRT
1/16/2012 - 12 years ago
14 - NON-FINAL ACTION WRITTENType:CNRT
12/16/2011 - 12 years ago
13 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
12/16/2011 - 12 years ago
12 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
12/14/2011 - 12 years ago
11 - ASSIGNED TO LIEType:ALIE
12/8/2011 - 12 years ago
10 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
8/20/2011 - 12 years ago
9 - REFUSAL PROCESSED BY IBType:RFNT
8/3/2011 - 12 years ago
8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IBType:RFCS
8/3/2011 - 12 years ago
7 - REFUSAL PROCESSED BY MPUType:RFRR
8/3/2011 - 12 years ago
6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEWType:RFCR
8/2/2011 - 12 years ago
5 - NON-FINAL ACTION WRITTENType:CNRT
8/1/2011 - 12 years ago
4 - ASSIGNED TO EXAMINERType:DOCK
6/28/2011 - 13 years ago
3 - APPLICATION FILING RECEIPT MAILEDType:MAFR
6/24/2011 - 13 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS
6/23/2011 - 13 years ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IBType:REPR